世界の創傷管理市場分析：2005‐2014 年

Abstract

This report will detail the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis will be given to advanced or leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) will be provided for established segments such as conventional dressings markets, though will be provided. The report will detail the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data will be presented for the U.S., leading western European countries, Japan and the Rest of World category. The report will profile leading and emerging companies, with equitable inclusion or exclusion of specific companies based on consistent criteria. The company profiles will provide detailed profile information on 15-20 major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced research activities in the market.

The report will establish the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and will assess and project the composition of the market as technologies gain or lose relative market performance over this period.

Table of Contents

Section 1: BACKGROUND

• 1.1 Industry Structure
• 1.2 A Complex Industry
• 1.3 Major Wound Management Corporations
• 1.4 Historical Perspective and Technology Breakthroughs
• 1.5 World-Wide Regulatory and Reimbursement Environment
• 1.5.1 Cost Effectiveness
• 1.5.2 Clinical
• 1.5.3 Regulatory
• 1.5.4 Reimbursement
• 1.5.4.1 U.S.A.
• 1.5.4.2 European Union
• 1.5.4.3 France
• 1.5.4.4 Germany
• 1.5.4.5 United Kingdom
• 1.5.4.6 Italy
• 1.5.4.7 Belgium
• 1.5.4.8 Spain
• 1.5.4.9 Scandinavia
• 1.6 Geographical Differences in Treatments of Wounds
• 1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence
• 1.8 Wound Management Trends
• 1.8.1 Surgical Wounds
• 1.8.2 Traumatic Wounds
• 1.8.3 Burns
• 1.8.4 Chronic Wounds
• 1.9 Market Dynamics

SECTION 2: CLINICAL BACKGROUND AND CASELOAD

• 2.1 Background
• 2.2 Wound Types
• 2.2.1 Classification By Severity
• 2.2.2 Classification By Morphology
• 2.2.3 Classification By Etiology
• 2.2.3.1 Surgical Wounds
• 2.2.3.2 Traumatic Wounds
• 2.2.3.3 Burns
• 2.2.3.4 Pressure Ulcers
• 2.2.3.5 Venous Ulcers
• 2.2.3.6 Arterial Ulcers
• 2.2.3.7 Diabetic Ulcers
• 2.2.3.8 Amputations
• 2.2.3.9 Abnormal Scarring
• 2.2.3.10 Acquired Immunodeficiency Syndrome
• 2.3 Wound Healing Physiology
• 2.3.1 Inflammatory Phase
• 2.3.2 Proliferative Phase
• 2.3.3 Maturation Phase
• 2.3.4 Factors Affecting Wound Healing
• 2.3.5 Extrinsic Factors
• 2.3.6 Mechanical Stress
• 2.3.7 Debris
• 2.3.8 Temperature
• 2.3.9 Desiccation and Maceration
• 2.3.10 Infection
• 2.3.11 Chemical Stress
• 2.3.12 Medication
• 2.3.13 Other Extrinsic Factors
• 2.3.14 Intrinsic Factors
• 2.3.15 Health Status
• 2.3.16 Age Factors
• 2.3.17 Body Build
• 2.3.18 Nutritional Status
• 2.4 Major Treatment Categories and Regimes
• 2.5 Incidence of Treatments, Growth Rates and Trends

SECTION 3: PRODUCTS, TECHNOLOGIES AND MARKETS

• 3.1 Background
• 3.2 Film Dressings
• 3.2.1 Overview
• 3.2.2 Product Examples
• 3.2.3 Market and Competitive Activity
• 3.3 Hydrocolloids
• 3.3.1 Overview
• 3.3.2 Product Examples
• 3.3.3 Market and Competitive Activity
• 3.4 Foam Dressings
• 3.4.1 Overview
• 3.4.2 Product Examples
• 3.4.3 Market and Competitive Activity
• 3.5 Alginate Dressings
• 3.5.1 Overview
• 3.5.2 Product Examples
• 3.5.3 Market and Competitive Activity
• 3.6 Hydrogels
• 3.6.1 Overview
• 3.6.2 Product Examples
• 3.6.3 Market and Competitive Activity
• 3.7 Non Adherent Dressings
• 3.7.1 Overview
• 3.7.2 Product Examples
• 3.7.3 Market and Competitive Activity
• 3.8 Antimicrobial Dressings
• 3.8.1 Overview
• 3.8.2 Product Examples
• 3.8.3 Market and Competitive Activity
• 3.9 Tissue Engineered Products
• 3.9.1 Overview
• 3.9.2 Product Examples
• 3.9.3 Market and Competitive Analysis
• 3.10 Pharmacological Products
• 3.10.1 Overview
• 3.10.2 Product Examples
• 3.10.2.1 Growth Factors
• 3.10.2.2 Non-Growth Factor Modulators
• 3.10.2.3 Gene Therapy
• 3.10.3 Market and Competitive Analysis
• 3.10.3.1 Growth Factors
• 3.10.3.2 Non-Growth Factor Stimulants
• 3.10.3.3 Gene Therapy
• 3.11 Physical Treatments
• 3.11.1 Overview
• 3.11.2 Product Examples
• 3.11.2.1 Pressure Devices
• 3.11.2.2 Hydrotherapy
• 3.11.2.3 Electrical Stimulation
• 3.11.2.4 Electromagnetic Stimulation Devices
• 3.11.2.5 Ultraviolet Therapy
• 3.11.2.6 Hyperbaric Oxygen Therapy
• 3.11.2.7 Mechanically Assisted Wound Closure Devices
• 3.11.2.8 Ultrasound Devices
• 3.11.2.9 Laser Devices
• 3.11.2.10 Wound Imaging/Documentation
• 3.11.3 Market and Competitive Analysis
• 3.11.3.1 Pressure Devices
• 3.11.3.2 Hydrotherapy
• 3.11.3.3 Electrical Stimulation
• 3.11.3.4 Hyperbaric Oxygen Therapy
• 3.11.3.5 Mechanically Assisted Wound Closure Devices
• 3.11.3.6 Lasers

SECTION 4: COUNTRY MARKET ANALYSIS

• 4.1 Global Overview
• 4.1.1 Market Estimates
• 4.1.2 Market potential
• 4.1.3 Leading Wound Care Companies
• 4.1.4 Leading National Markets
• 4.2 USA
• 4.2.1 Market Opportunity
• 4.2.2 Market for Advanced Wound Management Products
• 4.3 Japan
• 4.3.1 Wound Care Market
• 4.3.2 Market Opportunity
• 4.3.3 Leading Companies
• 4.4 Germany
• 4.4.1 Wound Care Market
• 4.4.2 Leading Companies
• 4.5 France
• 4.5.1 Wound Care Market
• 4.5.2 Leading Companies
• 4.6 Italy
• 4.6.1 Wound Care Market
• 4.6.2 Leading Companies
• 4.7 United Kingdom
• 4.7.1 Wound Care Market
• 4.7.2 Leading Companies

SECTION 5: COMPANY PROFILES

• 5.1 Major Companies
• 5.1.1 Bertek Pharmaceuticals (Mylan Labs.)
• 5.1.2 Carrington Laboratories Inc.
• 5.1.3 Coloplast Group
• 5.1.4 ConvaTec Inc.
• 5.1.5 Derma Sciences Inc.
• 5.1.6 DeRoyal Industries Inc.
• 5.1.7 Ethicon (Johnson & Johnson)
• 5.1.8 Gentell Inc.
• 5.1.9 Geritrex Corp.
• 5.1.10 Hartmann Group
• 5.1.11 Hollister Incorporated
• 5.1.12 Lohmann and Rauscher International GmbH and Co. KG
• 5.1.13 Medline
• 5.1.14 3M Group
• 5.1.15 Mnlycke AB
• 5.1.16 Smith and Nephew Group
• 5.1.17 Tyco International Ltd.
• 5.2 Specialist Companies
• 5.2.1 Antimicrobial Dressings
• 5.2.1.1 Acrymed Inc.
• 5.2..1.2 Argentum Products LLC
• 5.2.2 Oxygen Therapy
• 5.2.2.1 Perry Baromedical Corp.
• 5.2.3 Skin Substitutes
• 5.2.3.1 BioTissue Technologies AG
• 5.2.3.2 Fidia Group
• 5.2.3.3 Genzyme Biosurgery
• 5.2.3.4 Innogenetics
• 5.2.3.5 Integra Life Sciences Inc.
• 5.2.3.6 IsoTis S.A
• 5.2.3.7 Modex Therapeutics
• 5.2.3.8 Organogenesis Inc.
• 5.2.3.9 Ortec International Inc.
• 5.2.4 Hydrogels
• 5.2.4.1 Hydromer Inc.
• 5.2.5 Growth Factors
• 5.2.5.1 E.S. Cell International
• 5.2.6 Odour Control
• 5.2.6.1 CliniMed
• 5.2.7 Other Therapeutic Modalities
• 5.2.7.1 Anodyne Therapy LLC
• 5.2.7.2 Augustine Medical Inc./Arizant, Inc.
• 5.2.7.3 BioMedical Life Systems Inc
• 5.2.7.4 BlueSky Medical Group
• 5.2.7.5 Diapulse Corp of America
• 5.2.7.6 Electromedical Products International Inc.
• 5.2.7.7 Globalcare Medical
• 5.2.7.8 Kinetic Concepts Inc.
• 5.2.7.9 Koldcare
• 5.2.7.10 Microvas Technologies
• 5.2.7.11 Regenesis Biomedical Inc.
• 5.2.7.12 Roho Inc.
• 5.2.8 Summary Profiles
• 5.2.8.1 AciesHealth
• 5.2.8.2 Bard Medical Division
• 5.2.8.3 Biocore Medical Technologies Inc.
• 5.2.8.4 Biomarin Pharmaceuticals Inc.
• 5.2.8.5 Brennen Medical Inc.
• 5.2.8.6 Dermacor Inc.
• 5.2.8.7 Derma Rite Industries LLC
• 5.2.8.8 Encelle Inc.
• 5.2.8.9 Ferris Manufacturing Corp.
• 5.2.8.10 Fibrogen
• 5.2.8.11 Geistlich Pharma
• 5.2.8.12 HemCon Inc
• 5.2.8.13 Hymed Group Corporation
• 5.2.8.14 Integra Life Sciences Holdings Corp.
• 5.2.8.15 Laboratoires Urgo
• 5.2.8.16 L.A.M. Pharmaceutical Corp.
• 5.2.8.17 Lifewave Ltd
• 5.2.8.18 Longport Inc.
• 5.2.8.19 Microban International Ltd
• 5.2.8.20 Maersk Medical
• 5.2.8.21 Nagor Ltd.
• 5.2.8.22 SSL International Plc
• 5.2.8.23 Swiss American Products, Inc.

List of Exhibits

• Exhibit 1-1: Worldwide Wound Incidence by Etiology, 2005
• Exhibit 1-2: Advanced Wound Management, Worldwide Market Forecast, 2005-2014
• Exhibit 1-3: Active Wound Management Products, Worldwide Market Forecast, 2005-2014
• Exhibit 1-4: Total World Wound Management Products, Market Forecast, 2005-2014
• Exhibit 2-1: Classification of Wounds by Etiology
• Exhibit 2-2: Old and New Classification Systems for Burns
• Exhibit 2-3: Distribution of Pressure Ulcers
• Exhibit 3-1: Companies and Products in the Film Dressings Category
• Exhibit 3-2: Film Dressings, Worldwide Market Forecast, 2005-2014
• Exhibit 3-3: Film Dressings, Worldwide Market Share by Supplier, 2005
• Exhibit 3-4: Companies and Products in the Hydrocolloid Dressings Category
• Exhibit 3-5: Hydrocolloid Dressings, Worldwide Market Forecast, 2005-2014
• Exhibit 3-6: Hydrocolloid Dressings, Worldwide Market Share by Supplier, 2005
• Exhibit 3-7: Companies and Products in the Foam Dressings Category
• Exhibit 3-8: Foam Dressings, Worldwide Market Forecast, 2005-2014
• Exhibit 3-9: Foam Dressings, Worldwide Market Share by Supplier, 2005
• Exhibit 3-10: Companies and Products in the Alginate Dressings Category
• Exhibit 3-11: Alginate Dressings, Worldwide Market Forecast, 2005-2014
• Exhibit 3-12: Alginate Dressings, Worldwide Market Share by Supplier, 2005
• Exhibit 3-13: Amorphous Hydrogels - Companies and Products
• Exhibit 3-14: Impregnated Hydrogels -- Companies and Products
• Exhibit 3-15: Sheet Hydrogels -Companies and Products
• Exhibit 3-16: Hydrogel Dressings, Worldwide Market Forecast, 2005- 2014
• Exhibit 3-17: Hydrogel Dressings, Worldwide Market Share by Supplier, 2005
• Exhibit 3-18: Companies and Products in the Non-Adherent Dressings Category
• Exhibit 3-19: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Forecast, 2005-2014
• Exhibit 3-20: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Share by Supplier, 2005
• Exhibit 3-21: Companies and Products in the Dressings Category
• Exhibit 3-22: Antimicrobial Dressings, Worldwide Market Forecast, 2005-2014
• Exhibit 3-23: Antimicrobial Dressings, Worldwide Market Share by Supplier, 2005
• Exhibit 3-24: Companies and Products in the Tissue Engineering Category
• Exhibit 3-25: Skin Tissue Engineering Market, Worldwide Market Forecast, 2005-2014
• Exhibit 3-26: Tissue Engineering, Worldwide Share by Supplier, 2005
• Exhibit 3-27: Growth Factors in Wound Care, Worldwide Market Forecast, 2005-2014
• Exhibit 3-28: Companies Commercializing Technologies in the Physical Active Treatments Category
• Exhibit 3-29: Mechanically-Assisted Wound Closure, Worldwide Market Forecast, 2005-2014
• Exhibit 4-1: Summary Market Forecasts for Major Advanced Wound Management Product Groups, 2005-2014
• Exhibit 4-2: Leading Global Wound Care Companies
• Exhibit 4-3: National Shares of the Global Advanced Wound Management Market
• Exhibit 4-4: Forecast U.S. Sales for the Main Tpes of Advanced Wound Management Products for the Period 2005-2014
• Exhibit 4-5: Japanese Sales for the Main Types of Advanced Wound Management Products for the Period 2005-2014
• Exhibit 4-6: German Sales for the Main Types of Advanced Wound Management Products for the Period 2005-2014
• Exhibit 4-7: French Sales for the Main Types of Advanced Wound Management Products for the Period 2005-2014
• Exhibit 4-8: Italian Sales for the Main Types of Advanced Wound Management Products for the Period 2005-2014
• Exhibit 4-9: UK Sales for the Main Types of Advanced Wound Management Products for the Period 2005-2014
• Exhibit 5-1: Advanced Wound Management Products and Suppliers
• Exhibit 5-2: Hydrogel Dressings and Suppliers

APPENDIX: LIST OF COMPANIES